(Q34436682)

2 August 2017

1 reference

title

Epidermolysis bullosa acquisita: update and review (English)

1 reference

epidermolysis bullosa acquisita

2 August 2017

1 reference

Hallel-Halevy D

1

1 reference

2 August 2017

Nadelman C

series ordinal

2

1 reference

2 August 2017

Chen M

series ordinal

3

1 reference

2 August 2017

Woodley DT

series ordinal

4

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

Clinics in Dermatology

1 reference

2 August 2017

19

1 reference

2 August 2017

712-718

1 reference

2 August 2017

6

1 reference

Epidermolysis bullosa acquisita: ultrastructural and immunological studies

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Collagens and their abnormalities in a wide spectrum of diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Type VII collagen forms an extended network of anchoring fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Type VII collagen is a major structural component of anchoring fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Type VII collagen, anchoring fibrils, and epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

The Epidermal-Dermal Junction

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita--a pemphigoid-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Cutaneous changes in the porphyrias. A microscopic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita and associated symptomatic esophageal webs

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Differentiating Anti-Lamina Lucida and Anti-Sublamina Densa Anti-BMZ Antibodies by Indirect Immunofluorescence on 1.0 M Sodium Chloride-Separated Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita--a sign of cicatricial pemphigoid?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

A case of an inflammatory variant of epidermolysis bullosa acquisita: chronic bullous dermatosis associated with nonscarring mucosal blisters and circulating IgG anti-type-VII-collagen antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita localized to the face

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita in childhood--a case mimicking chronic bullous dermatosis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Ocular involvement in IgA-epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epitope spreading: lessons from autoimmune skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Localization of basement membrane components after dermal-epidermal junction separation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita diagnosed by direct immunoelectron microscopy of the conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Mucocutaneous features of autoimmune blistering diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

[Manifestation of epidermolysis bullosa acquisita (EBA) in the ENT area]

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2800%2900186-3

7 January 2021

10.1016/S0738-081X(00)00186-3

Identifiers

DOI

1 reference

2 August 2017

1 reference